News for Merck & Co., Inc. (MRK.PA)

Merck & Co., Inc. (NYSE:MRK) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ETCompany ParticipantsCaroline A.

Market Analysis by covering: Merck & Company Inc, Procter & Gamble Health Ltd, Verona Pharma PLC ADR. Read 's Market Analysis on Investing.com

The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. September E-mini S&P futures (ESU25 ) are up +0.03%, and September E-mini Nasdaq futures...

The U.S. stock market opened with modest gains today, as the Dow Jones Industrial Average rose 21.43 points, or 0.05%, to 44,858.99. The Nasdaq advanced

The following slide deck was published by Merck & Co., Inc.

Kickstart your trading day for July 29, 2025 with investingLive.com.

While reporting financial results for the second quarter on Tuesday, biopharmaceutical company Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, raised its adjusted earnings and sales guidance for the full-year 2025.

Merck offers a quarterly dividend amount of 81 cents per share. To receive $500 monthly, here's what you do.

Merck & Co., Inc. (NYSE:MRK) will release earnings results for the second quarter before the opening bell on Tuesday, July 29. Analysts expect the health care company to report quarterly earnings at $2.03 per share, down from $2.28 per share in the year-ago period. Merck projects to report quarterly revenue at $15.87 billion, compared to $16.11 billion a year earlier, according to data from Benzinga Pro. With the recent buzz around Merck, some investors may be eyeing potential gains from the com

Poster presentation of updated data on BT-001

The U.S. stock market concluded the trading week on Friday, July 25, 2025, with major indexes extending their record-setting rally, driven by a combination of

In the current market session, Merck & Co Inc. MRK share price is at $83.80, after a 0.21% decrease. Over the past month, the stock spiked by 6.65%, but over th...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Baron Health Care Fund declined for the quarter but outperformed its benchmark, the Russell 3000 Health Care Index. Read more here.

Merck (MRK) to maintain a steady quarterly dividend of $0.81 per share, offering a forward yield of 3.99%. Analysts predict an average price target of $

Merck (MRK) declares a quarterly dividend of $0.81 per share for Q4 2025. Dividend payable on October 7, 2025, to shareholders recorded by September 15,

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.81

In June 2025, the FDA approved KEYTRUDA for perioperative use in adults with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC) expressing PD-L1 (CPS ≥1).

Merck (MRK) has secured authorization from Health Canada for its immunotherapy drug, Keytruda, to be used alongside chemoradiotherapy in treating FIGO 2014 Stag